Crossmark

An association study on the risk, glucocorticoids effectiveness, and prognosis of systemic lupus erythematosus: insight from mitochondrial DNA copy number

Crossref DOI link: https://doi.org/10.1007/s12026-022-09318-4

Published Online: 2022-09-14

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Zhen

Zong, Qi-Qun

Zhai, Chun-Xia

Yu, Guang-Hui

Hu, Wan-Qin

Wang, Yu-Hua

Wang, Lin-Lin

Yan, Zi-Ye

Zhang, Ting-Yu

Teng, Ying

Liu, Shuang

Cai, Jing

Li, Mu

Chen, Yang-Fan

Ni, Jing

Cai, Guo-Qi

Cai, Pan-Yuan

Pan, Hai-Feng

Zou, Yan-Feng
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81872683, 81673254, 81872687, 82103933)
License Information

Text and Data Mining valid from 2022-09-14

Version of Record valid from 2022-09-14
More Information

Article History

Received: 15 May 2022

Accepted: 6 September 2022

First Online: 14 September 2022

Declarations

:

: The authors declare that they have no conflict of interest.

: The Ethical Committee of Anhui Medical University approved this study (approval number: 20180002).

Document is current

Any future updates will be listed below